IGC Pharma, Inc. (IGC)
0.334
-0.01
(-3.94%)
USD |
NYAM |
Dec 15, 16:00
0.3366
0.00 (0.00%)
Pre-Market: 07:59
IGC Pharma Research and Development Expense (Quarterly): 1.588M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Esperion Therapeutics, Inc. | 14.13M |
| Theravance Biopharma, Inc. | 7.707M |
| NRX Pharmaceuticals, Inc. | 1.429M |
| CEL-SCI Corp. | 3.740M |
| AIM ImmunoTech, Inc. | 0.525M |